Corona Remedies , an Ahmedabad-based pharmaceutical company, is set to launch its Initial Public Offering (IPO) next week to raise ₹655 cro re. The IPO will open for bids from December 8 to 10, with a price band ranging from ₹1,008 to ₹1,062 per share, each having a face value of ₹10. The issue will include a fresh issue of shares along with an offer for sale (OFS) by existing shareholders. Additionally, five percent of the net Qualified Institutional Buyer (QIB) portion has been reserved for Mutual Funds.